Silo Pharma, Inc. (SILO) — DEF 14A Filings
All DEF 14A filings from Silo Pharma, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Silo Pharma Proposes Reverse Stock Split, Board Elections at Annual Meeting
— Sep 5, 2025 Risk: high
Silo Pharma, Inc. (SILO) is holding its 2025 Annual Meeting on October 24, 2025, where shareholders will vote on several critical proposals. Key among these is -
Silo Pharma Files 2024 Proxy Statement
— Sep 18, 2024 Risk: low
Silo Pharma, Inc. filed a DEF 14A proxy statement on September 18, 2024, for its annual meeting on November 12, 2024. The company, previously known as Uppercut
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX